SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-002639
Filing Date
2019-08-14
Accepted
2019-08-14 17:17:37
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-063019.htm 10-Q 374219
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 9591
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 9734
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 4520
  Complete submission text file 0001683168-19-002639.txt   1964714

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20190630.xml EX-101.INS 258649
6 XBRL SCHEMA FILE xbio-20190630.xsd EX-101.SCH 23737
7 XBRL CALCULATION FILE xbio-20190630_cal.xml EX-101.CAL 34831
8 XBRL DEFINITION FILE xbio-20190630_def.xml EX-101.DEF 102269
9 XBRL LABEL FILE xbio-20190630_lab.xml EX-101.LAB 178521
10 XBRL PRESENTATION FILE xbio-20190630_pre.xml EX-101.PRE 150547
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 191027611
SIC: 2834 Pharmaceutical Preparations